Search Results
Sort by:
Filter 0
Sort by
12 July 2021 - 1926
Mechanisms leading to high-level resistance to ceftolozane/tazobactam and ceftazidime/avibactam in multidrug-resistant Pseudomonas aeruginosa isolates from northern Spain
09 July 2021 - 4811
Suboptimal ceftolozane/tazobactam (C/T) concentrations in continuous infusion could lead to the emergence of C/T resistance against Pseudomonas aeruginosa in an in vitro hollow fiber infection model
09 July 2021 - 4936
Staggered versus simultaneous administration of meropenem and amikacin in combined therapy against extensively drug-resistant Pseudomonas aeruginosa: may dosing schedule influence the initial decrease in the bacterial load?
24 April 2018 - P2428
Ceftolozane-tazobactam susceptibility in Pseudomonas aeruginosa isolate recovered from ICU patients with cUTIS and cIAIs in Spain. Results from the SUPERIOR multicenter study
23 April 2018 - P1701A
Efficacy of R1-pyocin in a murine model of acute Pseudomonas aeruginosa lung infection
23 April 2018 - P1392
Comparative analysis (HPLC) of peptidoglycans from acute vs chronic infection isolates of Pseudomonas aeruginosa
23 April 2018 - P1405
Relationship between phages and quorum sensing systems in isolates of Pseudomonas aeruginosa belonging to international cystic fibrosis clone (ST274_CC274)
22 April 2018 - P1173
Mechanisms of Pseudomonas aeruginosa beta-lactam resistance development independent of beta-lactamase production
22 April 2018 - O0576
Meropenem plus tobramycin combination dosage regimens against clinical hypermutable Pseudomonas aeruginosa at simulated epithelial lining fluid concentrations in the hollow-fibre infection model
22 April 2018 - P0631
Characterization of mutator Pseudomonas aeruginosa from Australian cystic fibrosis patients
21 April 2018 - O0128
In vitro synergistic effects of colistin plus meropenem combination on extensively drug-resistant (XDR) Pseudomonas aeruginosa high-risk clones
12 April 2016 - P1757
Role of the N-acetyl-anhydromuramyl-L-alanine-amidases (AmpDs) in the resistance of Pseudomonas aeruginosa to lysozyme, peptidoglycan recognition proteins (PGRPs) and osmotic shock
12 April 2016 - P1759
Contribution of Pseudomonas aeruginosa permeability barrier and lysozyme inhibitors to resistance against C-type bactericidal activity
11 April 2016 - P1370
Surfactant protein A recognizes outer membrane protein OprH on Pseudomonas aeruginosa cystic fibrosis isolates
11 April 2016 - P1315
Activity of ceftazidime/avibactam against Enterobacteriaceae producing extended-spectrum beta-lactamases and acquired AmpC beta-lactamases, including those lacking porin expression
10 April 2016 - P0492
Predictive model of 30-day mortality in a cohort of patients with bacteraemia due to extended spectrum beta-lactamases producing Enterobacteriaceae (ESBL-E): The INCREMENT Project
09 April 2016 - PLB42
WCK 5107 & WCK 5153: bicyclo-acyl hydrazides PBP2 inhibitors showing potent beta-lactam enhancer activity against Acinetobacter baumannii, including multidrug-resistant (MDR) carbapenemase-producing clinical strains
09 April 2016 - EV0666
Hypersusceptibility to r-pyocins of Pseudomonas aeruginosa clinical isolates from cystic fibrosis patients
09 April 2016 - EV0435
Emergence and clonal spread of carbapenem-resistant Klebsiella pneumoniae in BG
Loading ...
+ load more
FAQ
To access content in the Library you need to log in with your ESCMID member or user credentials. If you haven’t registered as an ESCMID member yet, then click here to do so – or use this link to register as a user.
The most recent event-related content is usually restricted to ESCMID members, while registered users get access one year after the event. However, there are events such as ESCMID Global where attendees get priority access, no matter if they are members or registered users. In these cases, we may offer non-attendees access after paying a fee.
You may search by event name, session title or number, topic title or number or author – or by any keyword. To get the most relevant results, enter the title or name in quotation marks, e.g. "Pre-ECCMID Day on Diagnostics" or "John Doe". If no quotation marks are used, then the exact result is shown first, followed by less exact results.
You may further narrow the number of search results for most terms by applying one or several filters, using the filter window on the start page. The Category and Media Type filters work for any content. In contrast, the Date from / to filter may not apply for Publications and Guidelines. In addition, the information text below a webcast or document offers the option of filtering search results by session title, author, event or category.
We defined four "hot topic" terms that you may search for by clicking the four tiles on the start page.
Linking two or more search terms by AND will show all results containing these search terms. For example, if you are looking for results that contain both the terms viral and hospital, then enter viral AND hospital.
Link two or more search terms by OR to get all results that contain at least one of these terms. For example, if you want to get results that contain either viral or infections or COVID, then enter viral OR infections OR COVID.
Place + in front of the term that you want to be included in your search result and place - in front of the term that you do not want to be included – without blanks in between in either case. For example, if you are aiming for search results that contain viral and infection but do not contain COVID, then enter +viral +infections -COVID.
A search term preceded by an exclamation point (no blanks in between) will lead to all content that does not contain the term, e.g. !COVID.
Deselect the ticked boxes in the filter dropdowns, click "Clear" on the calendars in the Date from / to filter – or refresh the website to remove all filters at once. Additionally, you may clear all applied filters by using the relevant buttons right above the search results.
No, as copyright protection limits the viewing of video presentations to web browsers, they cannot be downloaded.
No, due to our privacy policy we cannot disclose any contact details of persons involved.